Aura Biosciences Correlations

AURA Stock  USD 8.73  0.16  1.80%   
The current 90-days correlation between Aura Biosciences and Acrivon Therapeutics, Common is 0.39 (i.e., Weak diversification). The correlation of Aura Biosciences is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Aura Biosciences Correlation With Market

Weak diversification

The correlation between Aura Biosciences and DJI is 0.37 (i.e., Weak diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Aura Biosciences and DJI in the same portfolio, assuming nothing else is changed.
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Aura Biosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
For information on how to trade Aura Stock refer to our How to Trade Aura Stock guide.

Moving together with Aura Stock

  0.76MBIO Mustang BioPairCorr
  0.65RANI Rani TherapeuticsPairCorr
  0.82ABOS Acumen PharmaceuticalsPairCorr
  0.62AQST Aquestive TherapeuticsPairCorr
  0.63AVDL Avadel PharmaceuticalsPairCorr

Moving against Aura Stock

  0.45DYAI Dyadic InternationalPairCorr
  0.46BNTX BioNTech SE Downward RallyPairCorr
  0.37TELO Telomir Pharmaceuticals,PairCorr

Related Correlations Analysis

Click cells to compare fundamentals   Check Volatility   Backtest Portfolio

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.
High positive correlations   
CCCCCGEM
SEERAVTE
ACRVADAG
CGEMANEB
SEERANTX
CCCCANEB
  
High negative correlations   
CGEMSEER
ANEBSEER
CCCCSEER
CGEMANTX
ANEBAVTE
CGEMAVTE

Risk-Adjusted Indicators

There is a big difference between Aura Stock performing well and Aura Biosciences Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Aura Biosciences' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
AVTE  2.38  0.44  0.17  0.63  1.99 
 5.58 
 19.11 
ADAG  4.73 (0.35) 0.00 (1.28) 0.00 
 8.13 
 41.45 
ACRV  2.62 (0.41) 0.00 (0.21) 0.00 
 4.83 
 19.02 
RZLT  2.57 (0.25) 0.00 (0.28) 0.00 
 5.54 
 16.12 
ANTX  2.50  0.52  0.17  0.87  2.03 
 6.34 
 28.89 
SEER  2.15  0.55  0.23  0.78  1.74 
 6.32 
 15.38 
ORIC  2.82 (0.39) 0.00 (0.10) 0.00 
 5.15 
 20.53 
ANEB  4.69 (0.21) 0.00  0.32  0.00 
 7.64 
 76.00 
CGEM  2.87 (0.73) 0.00 (0.29) 0.00 
 5.88 
 17.85 
CCCC  3.65 (0.55) 0.00 (0.68) 0.00 
 9.28 
 23.66 

Aura Biosciences Corporate Management

Richard MountfieldSenior QualityProfile
Patrick NealonSenior OperationsProfile
CPE MBAChief RDProfile
Jill MDChief DevelopmentProfile
Amy ElazzouziInterim OfficerProfile
Paulo CarvalhoVP OperationsProfile
Bruce MDSenior OncologyProfile